GSK Pharma Reports 5.7% Q4 Profit Increase and FY26 Earnings Above Rs 1,000 Crore
17 minutes agoBusiness
30LENS
3 SourcesNew Delhi, India
TBNthebalanced.news

GSK Pharma Reports 5.7% Q4 Profit Increase and FY26 Earnings Above Rs 1,000 Crore

GlaxoSmithKline Pharmaceuticals Ltd reported a 5.7% rise in consolidated net profit to approximately Rs 278 crore for Q4 FY26, with revenue increasing to around Rs 995 crore. For the full fiscal year, net profit grew 11.7% to about Rs 1,036 crore, and revenue reached Rs 3,822 crore. Quarterly earnings declined sequentially from Q3 FY26, with profit and revenue falling by 6% and 4.4%, respectively. The company noted increased employee benefits expenses partly due to new Labour Code implementations and recorded exceptional gains from asset sales.

Political Bias
0%100%0%
Sentiment
68%
AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 13 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 3 sources
● Left 0%● Center 100%● Right 0%

The articles present a straightforward financial report without political framing. Coverage focuses on company performance metrics, regulatory impacts, and operational details, reflecting a business-centric perspective. There is no evident political bias, as the sources emphasize factual financial data and corporate disclosures without partisan commentary.

Sentiment — Positive (68/100)

The overall tone is neutral to mildly positive, highlighting profit growth and revenue increases while acknowledging sequential quarterly declines and expense rises. The inclusion of regulatory impacts and exceptional gains provides balanced context, avoiding overly optimistic or critical sentiment.

How 3 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
businessstandardGSK Pharma Q4 PAT rises 6 YoY to Rs 275 crCenterPositive
freepressjournalGlaxoSmithKline Pharma Q4 Profit Rises 6 To 278 Crore, FY26 Earnings Cross 1,000 CroreCenterPositive
news18GSK Pharma Q4 net profit rises 5.7 pc to Rs 277.86 crCenterNeutral

Coverage timeline

news18 broke this story on 13 May, 10:30 am. Other outlets followed.

  1. 1
    news1813 May, 10:30 am
    GSK Pharma Q4 net profit rises 5.7 pc to Rs 277.86 cr
  2. 2
    freepressjournal13 May, 10:31 am
    GlaxoSmithKline Pharma Q4 Profit Rises 6 To 278 Crore, FY26 Earnings Cross 1,000 Crore
  3. 3
    businessstandard13 May, 11:05 am
    GSK Pharma Q4 PAT rises 6 YoY to Rs 275 cr

Lens Score breakdown

30/100
Public interest0/100
Coverage gap100%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Corporate
GlaxoSmithKline Pharmaceuticals Ltd

Story context

Category
Business
Location
New Delhi, India
Sources analysed
3
Last analysed
13 May 2026
Key entities
CroreIndian rupeeGSK plcGlaxoSmithKline PharmaceuticalsDividendShareholderEquity (finance)Net incomeMedicationNew DelhiPress Trust of IndiaPharmaceutical industry